252 related articles for article (PubMed ID: 11386629)
1. Bayesian assessment of sample size for clinical trials of cost-effectiveness.
O'Hagan A; Stevens JW
Med Decis Making; 2001; 21(3):219-30. PubMed ID: 11386629
[TBL] [Abstract][Full Text] [Related]
2. A C++ program to calculate sample sizes for cost-effectiveness trials in a Bayesian framework.
Sarker SJ; Whitehead A; Khan I
Comput Methods Programs Biomed; 2013 Jun; 110(3):471-89. PubMed ID: 23399102
[TBL] [Abstract][Full Text] [Related]
3. A behavioural Bayes approach to the determination of sample size for clinical trials considering efficacy and safety: imbalanced sample size in treatment groups.
Kikuchi T; Gittins J
Stat Methods Med Res; 2011 Aug; 20(4):389-400. PubMed ID: 20223784
[TBL] [Abstract][Full Text] [Related]
4. The choice of sample size: a mixed Bayesian / frequentist approach.
Pezeshk H; Nematollahi N; Maroufy V; Gittins J
Stat Methods Med Res; 2009 Apr; 18(2):183-94. PubMed ID: 18445695
[TBL] [Abstract][Full Text] [Related]
5. Power and sample size calculations for stochastic cost-effectiveness analysis.
Briggs AH; Gray AM
Med Decis Making; 1998; 18(2 Suppl):S81-92. PubMed ID: 9566469
[TBL] [Abstract][Full Text] [Related]
6. A Bayesian predictive sample size selection design for single-arm exploratory clinical trials.
Teramukai S; Daimon T; Zohar S
Stat Med; 2012 Dec; 31(30):4243-54. PubMed ID: 22807115
[TBL] [Abstract][Full Text] [Related]
7. A behavioral Bayes method to determine the sample size of a clinical trial considering efficacy and safety.
Kikuchi T; Gittins J
Stat Med; 2009 Aug; 28(18):2293-306. PubMed ID: 19536745
[TBL] [Abstract][Full Text] [Related]
8. Bayesian sample size determination for a clinical trial with correlated continuous and binary outcomes.
Stamey JD; Natanegara F; Seaman JW
J Biopharm Stat; 2013; 23(4):790-803. PubMed ID: 23786161
[TBL] [Abstract][Full Text] [Related]
9. Bayesian estimation of cost-effectiveness from censored data.
Heitjan DF; Kim CY; Li H
Stat Med; 2004 Apr; 23(8):1297-309. PubMed ID: 15083484
[TBL] [Abstract][Full Text] [Related]
10. Bayesian estimation of cost-effectiveness: an importance-sampling approach.
Heitjan DF; Li H
Health Econ; 2004 Feb; 13(2):191-8. PubMed ID: 14737756
[TBL] [Abstract][Full Text] [Related]
11. A Bayesian approach to stochastic cost-effectiveness analysis.
Briggs AH
Health Econ; 1999 May; 8(3):257-61. PubMed ID: 10348420
[TBL] [Abstract][Full Text] [Related]
12. Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies.
O'Hagan A; Stevens JW
Stat Methods Med Res; 2002 Dec; 11(6):469-90. PubMed ID: 12516985
[TBL] [Abstract][Full Text] [Related]
13. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies.
Briggs AH; O'Brien BJ; Blackhouse G
Annu Rev Public Health; 2002; 23():377-401. PubMed ID: 11910068
[TBL] [Abstract][Full Text] [Related]
14. Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials.
Daimon T
Contemp Clin Trials; 2008 Jul; 29(4):507-16. PubMed ID: 18201944
[TBL] [Abstract][Full Text] [Related]
15. Performance and sample size requirements of Bayesian methods for binary outcomes in fixed-dose combination drug studies.
Holt MM; Stamey JD; Seaman JW; Young DM
J Biopharm Stat; 2009; 19(1):120-32. PubMed ID: 19127471
[TBL] [Abstract][Full Text] [Related]
16. Sample size reestimation by Bayesian prediction.
Wang MD
Biom J; 2007 Jun; 49(3):365-77. PubMed ID: 17623342
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of genuine prior information in cost-effectiveness analysis of clinical trial data.
Stevens JW; O'Hagan A
Int J Technol Assess Health Care; 2002; 18(4):782-90. PubMed ID: 12602079
[TBL] [Abstract][Full Text] [Related]
18. A new approach for sample size calculation in cost-effectiveness studies based on value of information.
Bader C; Cossin S; Maillard A; BĂ©nard A
BMC Med Res Methodol; 2018 Oct; 18(1):113. PubMed ID: 30348087
[TBL] [Abstract][Full Text] [Related]
19. Sample size determination for cost-effectiveness trials.
Willan AR
Pharmacoeconomics; 2011 Nov; 29(11):933-49. PubMed ID: 21988292
[TBL] [Abstract][Full Text] [Related]
20. A Bayesian approach for incorporating economic factors in sample size design for clinical trials of individual drugs and portfolios of drugs.
Patel NR; Ankolekar S
Stat Med; 2007 Nov; 26(27):4976-88. PubMed ID: 17579924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]